Integral Health Asset Management »

Gilead Sciences shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Gilead Sciences (GILD) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Gilead Sciences

Tip: Access up to 7 years of quarterly data

All positions including Gilead Sciences held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gilead Sciences by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $20M 175k 112.05
2024-12-31 $19M 200k 92.37
2022-12-31 $10M 120k 85.85

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Gilead Sciences

Vanguard Group
BlackRock
FMR
State Street Corporation
Capital World Investors
Dodge & Cox
Capital Research Global Investors
Geode Capital Management
Wellington Management Company
Morgan Stanley
Jpmorgan Chase & Co
Invesco
Northern Trust
Bank of New York Mellon
Ubs Global Asset Management Americas

View all funds holding Gilead Sciences